Thermo Fisher Scientific Sep 27, 2022 Thermo Fisher Gets FDA OK for CDx Test to Guide Use of Lilly Drug in Lung, Thyroid Cancers Aug 30, 2022 Thermo Fisher Scientific Obtains CE-IVD Mark for Targeted NGS Oncology Test, Analysis Software Aug 12, 2022 AstraZeneca, Daiichi Sankyo's Enhertu Scores FDA Accelerated Approval in HER2-Mutant Lung Cancer Mar 29, 2022 Thermo Fisher Scientific Obtains CE Mark for Ion Torrent Genexus Dx Integrated Sequencer Feb 25, 2022 Thermo Fisher Scientific Deal Expands Possibilities for Exosome Dx Business, Bio-Techne CEO Says Premium Dec 9, 2021 FDA Approves Thermo Fisher Scientific Oncomine Dx Assay as CDx for Janssen Lung Cancer Drug Nov 24, 2021 Local Cancer Genomic Profiling Options Grow, Though Central Labs Will Likely Keep Major Role Premium Sep 24, 2021 T Cell Repertoire Emerging as Potential Predictor in Neoadjuvant Lung Cancer Immunotherapy Premium Sep 16, 2021 FDA Approves Takeda's Exkivity With Thermo Fisher CDx for EGFR Exon20 Insertion-Positive NSCLC Sep 10, 2021 Japanese Health Ministry Clears Thermo Fisher Scientific Oncomine Assay as CDx for Lung Cancer Drug Sep 1, 2021 Thermo Fisher Scientific, AstraZeneca Team up to Develop CDx for Targeted Drugs Aug 26, 2021 FDA Clears Thermo Fisher Scientific Oncomine Assay as CDx for Bile Duct Cancer Drug Apr 29, 2021 TMB-High Status Does Not Predict Opdivo-Yervoy Response in Pan-Tumor Analysis Dec 9, 2020 Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project Nov 17, 2020 Diagnostics Firms, Lab Providers Form Genomic Profiling Coalition Sep 8, 2020 FDA Approves Thermo Fisher Scientific CDx for Genentech's Gavreto in NSCLC Patients With RET Fusions Aug 17, 2020 Thermo Fisher Scientific, Hengrui Therapeutics Ink CDx Deal for Pyrotinib in HER2-Mutated NSCLC Jul 8, 2020 Thermo Fisher Scientific, Chugai Pharmaceutical Sign Companion Diagnostic Agreement for NSCLC Jun 23, 2020 Thermo Fisher Scientific, Daiichi Sankyo Partner to Develop Non-Small Cell Lung Cancer CDx Jun 11, 2020 Thermo Fisher Scientific, Genetron Health Partner on NGS-Based Cancer Dx in China Load More Breaking News Marengo Therapeutics Begins Phase I/II Trial of Selective T-Cell-Targeted Antibody Janssen, Legend Biotech's Carvykti Bests Chemo in Earlier-Line Multiple Myeloma Trial In Brief This Week: PreludeDx, Johnson & Johnson, Syros, Magenta, Merck NICE Backs Gilead Sciences' Yescarta as Third-Line Option for Lymphoma Patients BMS Eyeing Breyanzi Indications in CLL, SLL After Positive Trial Data Enhertu Approved in Europe for HER2-Low Metastatic Breast Cancer
